NO20004872L - FremgangsmÕte for Õ stabilisere farmasøytiske sammensetninger ved spesiell anvendelse av en antioksidant - Google Patents

FremgangsmÕte for Õ stabilisere farmasøytiske sammensetninger ved spesiell anvendelse av en antioksidant

Info

Publication number
NO20004872L
NO20004872L NO20004872A NO20004872A NO20004872L NO 20004872 L NO20004872 L NO 20004872L NO 20004872 A NO20004872 A NO 20004872A NO 20004872 A NO20004872 A NO 20004872A NO 20004872 L NO20004872 L NO 20004872L
Authority
NO
Norway
Prior art keywords
antioxidant
pharmaceutical compositions
special use
stabilizing pharmaceutical
stabilizing
Prior art date
Application number
NO20004872A
Other languages
English (en)
Other versions
NO332004B1 (no
NO20004872D0 (no
Inventor
Gyoergy Lajos Kis
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20004872D0 publication Critical patent/NO20004872D0/no
Publication of NO20004872L publication Critical patent/NO20004872L/no
Publication of NO332004B1 publication Critical patent/NO332004B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20004872A 1998-04-02 2000-09-28 Fremgangsmate for a stabilisere en vandig farmasoytisk sammensetning, anvendelse av en antioksidant for a oppna nevnte stabilisering, samt en vandig oyensammensetning NO332004B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98106046 1998-04-02
PCT/EP1999/002221 WO1999051230A1 (en) 1998-04-02 1999-03-31 Method for stabilizing pharmaceutical compositions by special use of an antioxidant

Publications (3)

Publication Number Publication Date
NO20004872D0 NO20004872D0 (no) 2000-09-28
NO20004872L true NO20004872L (no) 2000-11-09
NO332004B1 NO332004B1 (no) 2012-05-21

Family

ID=8231706

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004872A NO332004B1 (no) 1998-04-02 2000-09-28 Fremgangsmate for a stabilisere en vandig farmasoytisk sammensetning, anvendelse av en antioksidant for a oppna nevnte stabilisering, samt en vandig oyensammensetning

Country Status (21)

Country Link
US (2) US6576649B1 (no)
EP (1) EP1098649B1 (no)
JP (1) JP2002510627A (no)
KR (1) KR100617430B1 (no)
CN (1) CN1138542C (no)
AT (1) ATE269079T1 (no)
AU (1) AU756000B2 (no)
BR (1) BR9909329A (no)
CA (1) CA2326137C (no)
CZ (1) CZ301851B6 (no)
DE (1) DE69918122T2 (no)
DK (1) DK1098649T3 (no)
ES (1) ES2224651T3 (no)
HU (1) HU226588B1 (no)
ID (1) ID26033A (no)
IL (2) IL138476A0 (no)
NO (1) NO332004B1 (no)
NZ (1) NZ507026A (no)
PL (1) PL194914B1 (no)
WO (1) WO1999051230A1 (no)
ZA (1) ZA200005098B (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0938896A1 (en) * 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent
US6235781B1 (en) 1998-07-14 2001-05-22 Alcon Laboratories, Inc. Prostaglandin product
BR0016550A (pt) * 1999-12-21 2002-09-17 Dsm Nv Preservação da atividade de um fungicida em uma solução aquosa.
US6395756B2 (en) * 1999-12-23 2002-05-28 Novartis Ag Use of ophthalmic agent
KR100355892B1 (ko) * 2000-01-06 2002-10-12 주식회사 코리아나화장품 레티놀과 테트라디부틸 펜타에리스리틸히드록시히드로신나메이트를 함유하는 화장료 조성물
JP4822609B2 (ja) * 2000-05-22 2011-11-24 クラレメディカル株式会社 抗菌性組成物
WO2001090251A1 (fr) * 2000-05-22 2001-11-29 Kuraray Co., Ltd. Composition antimicrobienne
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
ES2396598T3 (es) * 2000-08-25 2013-02-22 Senju Pharmaceutical Co., Ltd. Preparaciones en forma de suspensiones acuosas
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
WO2002100436A2 (en) * 2001-06-08 2002-12-19 Novartis Ag Ophthalmic once-a-day composition
US7479507B2 (en) * 2003-01-14 2009-01-20 Adam Heller Anti-inflammatory substituted phenols and elastomeric compositions for oral delivery of drugs
US6933289B2 (en) * 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
US20050220742A1 (en) * 2004-03-31 2005-10-06 Breen Ed V Compositions and methods for maintaining eyelid hygiene
US6969706B1 (en) * 2004-05-12 2005-11-29 Allergan, Inc. Preserved pharmaceutical compositions comprising cyclodextrins
CN1737047B (zh) * 2004-08-19 2010-05-05 住友化学株式会社 含填充材料的聚烯烃树脂组合物及其成形品
US20060089384A1 (en) * 2004-10-25 2006-04-27 Minno George E Ophthalmic compositions and methods of using the same
US20070208058A1 (en) * 2004-10-25 2007-09-06 Bryant Roy W Stable Pharmaceutical Compositions and Methods of Making and Using Same
EP1845983B1 (en) * 2004-10-25 2010-04-07 Bausch & Lomb Incorporated Ophthalmic compositions and methods of using the same
US20070077302A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for stabilizing ophthalmic compositions
BRPI0709549A2 (pt) * 2006-03-17 2011-07-19 Johnson & Johnson Vision Care métodos para estabilizar composições instáveis oxidativamente
JP2009543736A (ja) * 2006-07-10 2009-12-10 ジョンソン・アンド・ジョンソン・ビジョン・ケア・インコーポレイテッド 医薬品を含有する眼用レンズのためのパッケージ
ES2624960T3 (es) * 2006-09-29 2017-07-18 Johnson & Johnson Vision Care, Inc. Método de fabricación de dispositivos oftálmicos usados en el tratamiento de alergias oculares
US20090005362A1 (en) * 2007-06-26 2009-01-01 Vo Toan P Compositions Comprising Antihistamines or Mast Cell Stabilizers, and Methods of Making and Using Same
US8986728B2 (en) * 2008-05-30 2015-03-24 Abbott Cardiovascular Systems Inc. Soluble implantable device comprising polyelectrolyte with hydrophobic counterions
US8300252B2 (en) * 2008-06-18 2012-10-30 Livescribe, Inc. Managing objects with varying and repeated printed positioning information
CN102076340B (zh) * 2008-06-27 2013-01-23 祐德药品工业株式会社 含芬太尼或其盐的经皮吸收型贴剂
KR20100023538A (ko) * 2008-08-22 2010-03-04 삼성전자주식회사 고상 시약의 제조방법 및 고상 시약을 수용하는 미세유동장치
WO2010047681A1 (en) * 2008-10-24 2010-04-29 Bridge Pharma, Inc. Treating xerophthalmia with norketotifen
WO2010059894A1 (en) * 2008-11-21 2010-05-27 Bridge Pharma, Inc. Ocular formulations of norketotifen
KR101013102B1 (ko) * 2008-12-08 2011-02-14 주식회사 케이에스비 토너 카트리지의 블레이드 용접 장치
JP5675183B2 (ja) * 2009-06-16 2015-02-25 ロート製薬株式会社 水性組成物
FR2961694B1 (fr) * 2010-06-29 2013-01-25 Thea Lab Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur
US20180325854A1 (en) * 2015-11-06 2018-11-15 Accuitis Pharmaceuticals, Inc. Use of proteasome inhibitors to treat ocular disorders
CN114262476B (zh) * 2021-12-30 2023-09-05 沈阳兴齐眼药股份有限公司 提高妥布霉素滴眼液稳定性的包装容器
CN114262477B (zh) * 2021-12-30 2023-09-19 沈阳兴齐眼药股份有限公司 抑制妥布霉素滴眼液变色的包装容器及其制备方法
CN114441691B (zh) * 2022-04-12 2022-08-23 广州国标检验检测有限公司 一种眼用制剂容器中塑料添加剂的检测方法
US20240041869A1 (en) 2022-08-04 2024-02-08 Bausch + Lomb Ireland Limited Ophthalmic composition comprising an anti-allergen and a redness reduction agent
WO2024028816A1 (en) 2022-08-04 2024-02-08 Bausch + Lomb Ireland Limited Ophthalmic composition comprising pilocarpine and a redness reduction agent

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2231377B1 (no) * 1973-05-29 1977-11-04 Barnes Hind Pharm Inc
US3966905A (en) * 1973-05-29 1976-06-29 Barnes-Hind Pharmaceuticals, Inc. Stabilized catechol amine solutions
US4959208A (en) * 1987-10-19 1990-09-25 Ppg Industries, Inc. Active agent delivery device
JP3666884B2 (ja) * 1992-05-21 2005-06-29 日本ゼオン株式会社 医療用器材
JP3098895B2 (ja) * 1993-06-28 2000-10-16 三菱化学株式会社 液体用容器
JP3021312B2 (ja) * 1994-03-15 2000-03-15 千寿製薬株式会社 プラノプロフェンの安定化方法および安定なプラノプロフェン水性液剤
JP3055753B2 (ja) * 1994-07-05 2000-06-26 昭和薬品化工株式会社 フマル酸ケトチフェン含有点眼液
JP3693696B2 (ja) * 1994-12-15 2005-09-07 久光製薬株式会社 ケトチフェン含有経皮投与製剤
ES2144264T3 (es) * 1995-08-29 2000-06-01 Exxon Chemical Patents Inc Polipropileno tolerante a la radiacion y sus articulos utiles.
KR100228514B1 (ko) * 1996-09-05 1999-11-01 한승수 비스테로이드성 소염진통제를 활성성분으로 하는 경피흡수제제의 제조방법

Also Published As

Publication number Publication date
JP2002510627A (ja) 2002-04-09
ID26033A (id) 2000-11-16
KR100617430B1 (ko) 2006-08-31
IL138476A (en) 2006-04-10
US6576649B1 (en) 2003-06-10
HUP0101582A3 (en) 2002-10-28
ATE269079T1 (de) 2004-07-15
CZ20003579A3 (cs) 2001-01-17
CA2326137C (en) 2009-06-02
AU3811999A (en) 1999-10-25
EP1098649B1 (en) 2004-06-16
KR20010042361A (ko) 2001-05-25
NZ507026A (en) 2003-09-26
EP1098649A1 (en) 2001-05-16
HU226588B1 (en) 2009-04-28
ZA200005098B (en) 2001-05-21
CN1295474A (zh) 2001-05-16
PL343156A1 (en) 2001-07-30
AU756000B2 (en) 2003-01-02
DE69918122D1 (de) 2004-07-22
NO332004B1 (no) 2012-05-21
CZ301851B6 (cs) 2010-07-07
ES2224651T3 (es) 2005-03-01
DK1098649T3 (da) 2004-10-04
US6455547B1 (en) 2002-09-24
PL194914B1 (pl) 2007-07-31
DE69918122T2 (de) 2005-06-16
US20020103196A1 (en) 2002-08-01
NO20004872D0 (no) 2000-09-28
IL138476A0 (en) 2001-10-31
CA2326137A1 (en) 1999-10-14
WO1999051230A1 (en) 1999-10-14
BR9909329A (pt) 2000-12-12
CN1138542C (zh) 2004-02-18
HUP0101582A2 (hu) 2002-03-28

Similar Documents

Publication Publication Date Title
NO20004872D0 (no) FremgangsmÕte for Õ stabilisere farmasøytiske sammensetninger ved spesiell anvendelse av en antioksidant
DE69737592D1 (de) Mittel gegen juckreiz
NO20034056D0 (no) Proliferative sykdommer
WO2003073999A3 (en) Pini-modulating compounds and methods of use thereof
EA199900373A2 (ru) Фармацевтические композиции
BR0215405A (pt) Composições e processos de uso de collajolie
WO2002030353A3 (en) NF-λB INHIBITORS
DK1056454T3 (da) Anvendelse af makrolidforbindelser til behandling af glaukom
DK0450991T3 (da) Anvendelse af phospholipider til behandling af luftvejsobstruktionssygdomme
IL157669A0 (en) Nitrogen-based camptothecin derivatives
ATE386742T1 (de) Imidazonaphthyridine
WO2005007123A3 (en) Pin1-modulating compounds and methods of use thereof
WO2001087287A3 (en) Use of pyrazole derivatives for treating infertility
NO20033318L (no) 2H-1-benzopyranderivater, fremgangsmåte ved fremstilling samt farmasöytiskesammensetninger derav
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
NO983511D0 (no) Difenylstilbener som pro-legemidler for COX-2-inhibitorer
EA200000522A1 (ru) 5-htагонисты
AU2576901A (en) Agents and methods for the treatment of proliferative diseases
MXPA05009428A (es) Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas.
WO2002026730A3 (en) Fluorinated quinolones as antimitotic and antitumor agents
EP1436279B8 (en) Chemical compounds
PT1144348E (pt) Inibidores de lta, hidrolase
BR0214244A (pt) Uso de uma ascomicina
DE50211752D1 (de) Wässrige lösungen von moxaverin zur behandlung der erektilen dysfunktion

Legal Events

Date Code Title Description
MK1K Patent expired